SLC5A2 and type 2 diabetes mellitus: Thus, SGLT-2 inhibitors have numerous remarkable effects on suppressing the progression of HF and preventing adverse cardiac remodeling in T2DM through multiple molecular mechanisms, part of them exhibiting gender-based activity and being under the control of autocrine signaling pathways.